SCHEMBL19182133

SCHEMBL19182133

O=Cc1coc2cc(Br)ccc2c1=O

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 14/20 0.77
▸ PTPN2 P17706 2/20 0.61
▸ MAOA P21397 2/20 0.60
▸ MAOB P27338 2/20 0.60
▸ MAPT P10636 4/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ PKM P14618 1/20 0.58
▸ HTT P42858 2/20 0.54
▸ GAA P10253 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ HSP90AA1 P07900 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ POLB P06746 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ THRB P10828 1/20 0.44
▸ RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29529294 1.00 PTPN1 (0.77) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL177572 0.87 PTPN1 (1.00) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL19180463 0.81 MAPT (0.67) PTPN1MAOAMAOBMAPTALDH1A1
SCHEMBL19180460 0.81 MAPT (0.67) PTPN1MAOAMAOBMAPTALDH1A1
SCHEMBL28564467 0.80 PTPN1 (0.77) PTPN1PTPN2MAOAMAOBALDH1A1
SCHEMBL29954829 0.80 PTPN1 (0.61) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL1861100 0.80 PTPN1 (0.61) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL29956322 0.80 PTPN1 (0.61) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL29958044 0.80 PTPN1 (0.77) PTPN1PTPN2MAOAMAOBMAPT
SCHEMBL15951253 0.77 PTPN1 (0.78) PTPN1PTPN2MAOAMAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3407974-A1 AMLEXANOX ANALOGS The Regents Of The University Of Michigan (US) 2018-12-05 — — EP disclosed
US-20170217980-A1 AMLEXANOX ANALOGS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2017-08-03 — — US disclosed
US-20170217980-A1 AMLEXANOX ANALOGS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2017-08-03 — — US disclosed
US-20170217980-A1 AMLEXANOX ANALOGS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2017-08-03 — — US disclosed
WO-2017132538-A1 AMLEXANOX ANALOGS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-08-03 — — WO disclosed
WO-2017132538-A1 AMLEXANOX ANALOGS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-08-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217980-A1 AMLEXANOX ANALOGS GPR119, GLP1R, IRS1 PTPN1 1458/4885PTPN2 1754/4885MAOA 4594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback